Is combined use of radiofrequency ablation and balloon dilation the future of interatrial communications?

References

• Galiè N, Humbert M, Vachiery JL, ESC Scientific Document Group, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): endorsed by: association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Heart J. 2015;37(1):67–119. PMID: 26320113.
   PubMed Web of Science ®Google Scholar
• Khan MS, Memon MM, Amin E, et al. Use of balloon atrial septostomy in patients with advanced pulmonary arterial hypertension: a systematic review and meta-analysis. Chest. 2019;156(1):53–63. PMID: 30910639.
   PubMed Web of Science ®Google Scholar
• Hasenfuß G, Hayward C, Burkhoff D, et al. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet. 2016;387(10025):1298–1304. PMID: 27025436.
   PubMed Web of Science ®Google Scholar
• Lauder L, Pereira TV, Degenhardt MC, et al. Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: a systematic review and meta-analysis. Eur J Heart Fail. 2021;23(11):1960–1970. PMID: 34628706.
   PubMed Web of Science ®Google Scholar
• Rich S, Dodin E, McLaughlin VV, et al. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am J Cardiol. 1997;80(3):369–371. PMID: 9264443.
   PubMed Web of Science ®Google Scholar
• Sandoval J, Gaspar J, Pulido T, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol. 1998;32(2):297–304.
   PubMed Web of Science ®Google Scholar
• Park SC, Neches WH, Zuberbuhler JR, et al. Clinical use of blade atrial septostomy. Circulation. 1978;58(4):600–606. PMID: 688569.
   PubMed Web of Science ®Google Scholar
• Park SC, Neches WH, Mullins CE, et al. Blade atrial septostomy: collaborative study. Circulation. 1982;66(2):258–266. PMID: 7094235.
   PubMed Web of Science ®Google Scholar
• Lammers AE, Derrick G, Haworth SG, et al. Efficacy and long-term patency of fenestrated amplatzer devices in children. Catheter Cardiovasc Interv. 2007;70(4):578–584. PMID: 17896406.
   PubMed Web of Science ®Google Scholar
• Althoff TF, Knebel F, Panda A, et al. Long-term follow up of a fenestrated amplatzer atrial septal occluder in pulmonary arterial hypertension. Chest. 2008;133(1):283–285. PMID: 18187754.
   PubMed Web of Science ®Google Scholar
• Danon S, Levi DS, Alejos JC, et al. Reliable atrial septostomy by stenting of the atrial septum. Catheter Cardiovasc Interv. 2005;66(3):408–413. PMID: 16216026.
   PubMed Web of Science ®Google Scholar
• Roy AK, Gaine SP, Walsh KP. Percutaneous atrial septostomy with modified butterfly stent and intracardiac echocardiographic guidance in a patient with syncope and refractory pulmonary arterial hypertension. Heart Lung Circ. 2013;22(8):668–671. PMID: 23402682.
   PubMed Web of Science ®Google Scholar
• Chaturvedi RR, Ryan G, Seed M, et al. Fetal stenting of the atrial septum: technique and initial results in cardiac lesions with left atrial hypertension. Int J Cardiol. 2013;168(3):2029–2036. PMID: 23481911.
   PubMed Web of Science ®Google Scholar
• Coe JY, Chen RP, Timinsky J, et al. A novel method to create atrial septal defect using a cutting balloon in piglets. Am J Cardiol. 1996;78(11):1323–1326. PMID: 8960605.
   PubMed Web of Science ®Google Scholar
• Schneider MBE, Zartner PA, Magee AG. Transseptal approach in children after patch occlusion of atrial septal defect: first experience with the cutting balloon. Cathet Cardiovasc Interv. 1999;48(4):378–381. PMID: 10559818.
   PubMed Web of Science ®Google Scholar
• Amat-Santos IJ, Bergeron S, Bernier M, et al. Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device. EuroIntervention. 2015;10(9):1127–1131. PMID: 24832489.
   PubMed Web of Science ®Google Scholar
• Rajeshkumar R, Pavithran S, Sivakumar K, et al. Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension. Catheter Cardiovasc Interv. 2017;90(7):1145–1153. PMID: 28862384.
   PubMed Web of Science ®Google Scholar
• Søndergaard L, Reddy V, Kaye D, et al. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure. Eur J Heart Fail. 2014;16(7):796–801. PMID: 24961390.
   PubMed Web of Science ®Google Scholar
• Simard T, Labinaz M, Zahr F, et al. Percutaneous atriotomy for levoatrial-to-coronary sinus shunting in symptomatic heart failure: first-in-human experience. JACC Cardiovasc Interv. 2020;13(10):1236–1247. PMID: 32438996.
   PubMed Web of Science ®Google Scholar
• Yan C, Niu G, Niu H, et al. Stable interatrial communication combining balloon atrial septostomy and radiofrequency catheter ablation. J Am Coll Cardiol. 2018;72(15):1873–1875. PMID: 30286932.
   PubMed Web of Science ®Google Scholar
• Yan C, Wan L, Li H, et al. First in-human modified atrial septostomy combining radiofrequency ablation and balloon dilation. Heart. 2022 Oct 13 2022. 108(21):1690–1698.
   Web of Science ®Google Scholar
• Sun W, Zou H, Yong Y, et al. The raise trial: a novel device and first-in-man trial. Circ Heart Fail. 2022;15(4):e008362. PMID: 35378984.
   PubMed Web of Science ®Google Scholar
• Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy: a palliative approach to complete transposition of the great arteries. JAMA. 1966;196(11):991–992.
   PubMed Web of Science ®Google Scholar
• Parsons CG, Astley R, Burrows FG, et al. Transposition of great arteries. A study of 65 infants followed for 1 to 4 years after balloon septostomy. Br Heart J. 1971;33(5):725–731. PMID: 5115017.
   PubMedGoogle Scholar
• Mullins CE, el-Said GM, Neches WH, et al. Balloon atrial septostomy for total anomalous pulmonary venous return. Br Heart J. 1973;35(7):752–757. PMID: 4268891.
   PubMedGoogle Scholar
• Ward KE, Mullins CE, Huhta JC, et al. Restrictive interatrial communication in total anomalous pulmonary venous connection. Am J Cardiol. 1986;57(13):1131–1136. PMID: 3706165.
   PubMed Web of Science ®Google Scholar
• Baylen BG, Grzeszczak M, Gleason ME, et al. Role of balloon atrial septostomy before early arterial switch repair of transposition of the great arteries. J Am Coll Cardiol. 1992;19(5):1025–1031. PMID: 1552089.
   PubMed Web of Science ®Google Scholar
• Atz AM, Feinstein JA, Jonas RA, et al. Preoperative management of pulmonary venous hypertension in hypoplastic left heart syndrome with restrictive atrial septal defect. Am J Cardiol. 1999;83(8):1224–1228. PMID: 10215289.
   PubMed Web of Science ®Google Scholar
• Cheatham JP. Intervention in the critically ill neonate and infant with hypoplastic left heart syndrome and intact atrial septum. J Interv Cardiol. 2001;14(3):357–366. PMID: 12053397.
   PubMedGoogle Scholar
• Vlahos AP, Lock JE, McElhinney DB, et al. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy. Circulation. 2004;109(19):2326–2330. PMID: 15136496.
   PubMed Web of Science ®Google Scholar
• Gossett JG, Rocchini AP, Lloyd TR, et al. Catheter-based decompression of the left atrium in patients with hypoplastic left heart syndrome and restrictive atrial septum is safe and effective. Catheter Cardiovasc Interv. 2006;67(4):619–624. PMID: 16547929.
   PubMed Web of Science ®Google Scholar
• Pedra CA, Neves JR, Pedra SR, et al. New transcatheter techniques for creation or enlargement of atrial septal defects in infants with complex congenital heart disease. Catheter Cardiovasc Interv. 2007;70(5):731–739. PMID: 17621660.
   PubMed Web of Science ®Google Scholar
• Holzer RJ, Wood A, Chisolm JL, et al. Atrial septal interventions in patients with hypoplastic left heart syndrome. Catheter Cardiovasc Interv. 2008;72(5):696–704. PMID: 18942130.
   PubMed Web of Science ®Google Scholar
• Al Senaidi K, Al Mesned A, Coe JY. Percutaneous transhepatic stenting of a restrictive atrial septal communication in hypoplastic left heart syndrome. Catheter Cardiovasc Interv. 2014;83(7):E269–71. PMID: 24532371.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan A, Sasidharan B, Krishnamoorthy KM, et al. Left ventricular regression after balloon atrial septostomy in d-transposition of the great arteries. Eur J Cardiothorac Surg. 2016;50(6):1096–1101. PMID: 27307481.
   PubMed Web of Science ®Google Scholar
• Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J. 1986;55(5):449–458. PMID: 3707785.
   PubMedGoogle Scholar
• D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. results from a national prospective registry. Ann Intern Med. 1991;115(5):343–349. PMID: 1863023.
   PubMed Web of Science ®Google Scholar
• Hopkins WE, Ochoa LL, Richardson GW, et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant. 1996;15(1):100–105. PMID: 8820089.
   PubMed Web of Science ®Google Scholar
• Austen WG, Morrow AG, Berry WB. Experimental studies of the surgical treatment of primary pulmonary hypertension. J Thorac Cardiovasc Surg. 1964;48:448–455. PMID: 14218643.
   PubMed Web of Science ®Google Scholar
• Rich S, Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. Am J Cardiol. 1983;51(9):1580–1581.
   Web of Science ®Google Scholar
• Law MA, Grifka RG, Mullins CE, et al. Atrial septostomy improves survival in select patients with pulmonary hypertension. Am Heart J. 2007;153(5):779–784.
   PubMed Web of Science ®Google Scholar
• Ciarka A, Vachièry JL, Houssière A, et al. Atrial septostomy decreases sympathetic overactivity in pulmonary arterial hypertension. Chest. 2007;131(6):1831–1837.
   PubMed Web of Science ®Google Scholar
• Sandoval J, Gaspar J, Peña H, et al. Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur Respir J. 2011;38(6):1343–1348. PMID: 21349914.
   PubMed Web of Science ®Google Scholar
• Koeken Y, Kuijpers NH, Lumens J, et al. Atrial septostomy benefits severe pulmonary hypertension patients by increase of left ventricular preload reserve. Am J Physiol Heart Circ Physiol. 2012;302(12)):H2654–62. PMID: 22523252.
   PubMed Web of Science ®Google Scholar
• Chiu JS, Zuckerman WA, Turner ME, et al. Balloon atrial septostomy in pulmonary arterial hypertension: effect on survival and associated outcomes. J Heart Lung Transplant. 2015;34(3):376–380. PMID: 25813766.
   PubMed Web of Science ®Google Scholar
• Allcock RJ. Atrial septostomy for pulmonary arterial hypertension. Heart. 2003;89(11):1344–1347. PMID: 14594898.
   PubMed Web of Science ®Google Scholar
• Kurzyna M, Dabrowski M, Bielecki D, et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest. 2007;131(4):977–983. PMID: 17426198.
   PubMed Web of Science ®Google Scholar
• Rothman A, Sklansky MS, Lucas VW, et al. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol. 1999;84(6):682–686. PMID: 10498139.
   PubMed Web of Science ®Google Scholar
• Micheletti A, Hislop AA, Lammers A, et al. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart. 2006;92(7):969–972. PMID: 16278272.
   PubMed Web of Science ®Google Scholar
• Kuhn BT, Javed U, Armstrong EJ, et al. Balloon dilation atrial septostomy for advanced pulmonary hypertension in patients on prostanoid therapy. Catheter Cardiovasc Interv. 2015;85(6):1066–1072. PMID: 25413481.
   PubMed Web of Science ®Google Scholar
• Bauer A, Khalil M, Schmidt D, et al. Creation of a restrictive atrial communication in pulmonary arterial hypertension (PAH): effective palliation of syncope and end-stage heart failure. Pulm Circ. 2018;8(2):2045894018776518. PMID: 29693479.
   Web of Science ®Google Scholar
• Del Trigo M, Bergeron S, Bernier M, et al. Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study. Lancet. 2016;387(10025):1290–1297. PMID: 27025435.
   PubMed Web of Science ®Google Scholar
• Wessler J, Kaye D, Gustafsson F, et al. REDUCE-LAP-HF trial investigators and advisors. Impact of baseline hemodynamics on the effects of a transcatheter interatrial shunt device in heart failure with preserved ejection fraction. Circ Heart Fail. 2018;11(8):e004540. PMID: 30354556.
   PubMed Web of Science ®Google Scholar
• Feldman T, Mauri L, Kahwash R, et al. REDUCE LAP-HF I investigators and study coordinators. transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [reduce elevated left atrial pressure in patients with heart failure]): a phase 2, Randomized, Sham-Controlled Trial. Circulation. 2018;137(4):364–375. PMID: 29142012.
   PubMed Web of Science ®Google Scholar
• Obokata M, Reddy YNV, Shah SJ, et al. Effects of interatrial shunt on pulmonary vascular function in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2019;74(21):2539–2550. PMID: 31753198.
   PubMed Web of Science ®Google Scholar
• Volpe M, Liuzzo G. Unloading left heart with a shunt device shows no benefits in heart failure with preserved ejection fraction but supports the importance of phenotyping patients in clinical trials. Eur Heart J. 2022;43(18):1700–1701. PMID: 35325080.
   PubMed Web of Science ®Google Scholar
• Saunders A, Michelakis E. Atrial shunt devices in patients with heart failure and preserved or mildly reduced ejection fraction and the pulmonary circulation: promises and concerns. Circulation. 2022;145(21):1605–1608. PMID: 35605032.
   PubMed Web of Science ®Google Scholar
• Shah SJ, Borlaug BA, Chung ES, et al. REDUCE LAP-HF II investigators. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet. 2022;399(10330):1130–1140. PMID: 35120593.
   PubMed Web of Science ®Google Scholar
• Borlaug BA, Blair J, Bergmann MW, et al. REDUCE LAP-HF-II investigators. latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure. Circulation. 2022;145(21):1592–1604. Epub 2022 Mar 31. [PMID: 35354306].
   PubMed Web of Science ®Google Scholar
• Paitazoglou C, Özdemir R, Pfister R, et al. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the atrial flow regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction. EuroIntervention. 2019;15(5):403–410. PMID: 31130524.
   PubMed Web of Science ®Google Scholar
• Guimarães L, Bergeron S, Bernier M, et al. Interatrial shunt with the second-generation V-Wave system for patients with advanced chronic heart failure. EuroIntervention. 2020;15(16):1426–1428. PMID: 31422927.
   PubMed Web of Science ®Google Scholar
• Paitazoglou C, Bergmann MW, Özdemir R, et al. AFR-PRELIEVE investigators. One-year results of the first-in-man study investigating the atrial flow regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study. Eur J Heart Fail. 2021;23(5):800–810. PMID: 33555114.
   PubMed Web of Science ®Google Scholar
• Kuhn MA, Larsen RL, Mulla NF, et al. Outcome of infants with hypoplastic left heart syndrome who undergo atrial septostomy before heart transplantation. Am J Cardiol. 2000;85(1):124–7, A9. PMID: 11078255.
   PubMed Web of Science ®Google Scholar
• Seib PM, Faulkner SC, Erickson CC, et al. Blade and balloon atrial septostomy for left heart decompression in patients with severe ventricular dysfunction on extracorporeal membrane oxygenation. Catheter Cardiovasc Interv. 1999;46(2):179–186. PMID: 10348539.
   PubMed Web of Science ®Google Scholar
• Johnston TA, Jaggers J, McGovern JJ, et al. Bedside transseptal balloon dilation atrial septostomy for decompression of the left heart during extracorporeal membrane oxygenation. Catheter Cardiovasc Interv. 1999;46(2):197–199. PMID: 10348543.
   PubMed Web of Science ®Google Scholar
• Abraham BP, Gilliam E, Kim DW, et al. Early catheterization after initiation of extracorporeal membrane oxygenation support in children is associated with improved survival. Catheter Cardiovasc Interv. 2016;88(4):592–599. PMID: 27037743.
   PubMed Web of Science ®Google Scholar
• Baruteau AE, Barnetche T, Morin L, et al. Percutaneous balloon atrial septostomy on top of venoarterial extracorporeal membrane oxygenation results in safe and effective left heart decompression. Eur Heart J Acute Cardiovasc Care. 2018;7(1):70–79. PMID: 27742755.
   PubMed Web of Science ®Google Scholar
• Piliero N, Bedague D, Fournel E, et al. The atrial flow regulator: a novel device for left ventricular unloading in patients receiving venoarterial extracorporeal membrane oxygenation support? Chest. 2021;160(2):e165–7. PMID: 34366037.
   PubMed Web of Science ®Google Scholar
• Aregullin EO, Samuel BP, Girgis R, et al. Emergency use of occlutech® atrial flow regulator device facilitates weaning from veno-arterial extracorporeal membrane oxygenation in a patient with severe pulmonary arterial hypertension. J Intensive Care Med. 2021;36(6):726–728. PMID: 33853402.
   PubMed Web of Science ®Google Scholar
• Kloeckner M, Guihaire J, Hascoet S. Congestive pulmonary oedema during venoarterial extracorporeal membrane oxygenation support: a plea for balloon atrial septostomy. Eur Heart J. 2021;42(32):3103–3104. PMID: 33675638.
   PubMed Web of Science ®Google Scholar
• Chandrashekar P, Park JY, Al-Hijji MA, et al. Atrial septostomy to treat stiff left atrium syndrome. Circ Heart Fail. 2017;10(7):e004160. PMID: 28694356.
   PubMed Web of Science ®Google Scholar
• Zaidi D, Williams D, Zhao D, et al. Interatrial stent to treat stiff left atrium syndrome. Cardiovasc Revasc Med. 2022;40S:337–340. PMID: 35105508.
   PubMedGoogle Scholar
• Kernis SJ, Goldstein J, Yerkey M, et al. Percutaneous atrial septostomy for urgent palliative treatment of severe refractory cardiogenic shock due to right ventricular infarction. Catheter Cardiovasc Interv. 2003;59(1):44–48. PMID: 12720239.
   PubMed Web of Science ®Google Scholar
• Vyas H, Driscoll DJ, Cabalka AK, et al. Results of transcatheter fontan fenestration to treat protein losing enteropathy. Catheter Cardiovasc Interv. 2007;69(4):584–589. PMID: 17323361.
   PubMed Web of Science ®Google Scholar
• Kerstein D, Levy PS, Hsu DT, et al. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation. 1995;91(7):2028–2035. PMID: 7534664.
   PubMed Web of Science ®Google Scholar
• Hill SL, Mizelle KM, Vellucci SM, et al. Radiofrequency peroration and cutting balloon septoplasty in a newborn with hypoplastic left heart syndrome using transesophageal ICE probe guidance. Cathet Cardiovasc Interv. 2005;64(2):214–217. PMID: 15678458.
   PubMed Web of Science ®Google Scholar
• Bauer F, Besnier E, Aludaat C, et al. Left atrial unloading with an 8 mm septal cutting balloon to treat postcapillary pulmonary hypertension: a case report. ESC Heart Fail. 2022;9(1):782–785. PMID: 34766440.
   PubMed Web of Science ®Google Scholar
• Guerrero M, Cajigas H, Awdish R, et al. First-in-man experience with cryoplasty during graded balloon atrial septostomy to reduce spontaneous closure in a patient with severe pulmonary arterial hypertension. EuroIntervention. 2014;9(10):1235–1236. PMID: 24561738]. First in-human use of cryoplasty during balloon atrial septostomy.
   PubMed Web of Science ®Google Scholar
• O’Loughlin AJ, Keogh A, Muller DW. Insertion of a fenestrated amplatzer atrial septostomy device for severe pulmonary hypertension. Heart Lung Circ. 2006;15(4):275–277. PMID: 16857426.
   PubMedGoogle Scholar
• Prieto LR, Latson LA, Jennings C. Atrial septostomy using a butterfly stent in a patient with severe pulmonary arterial hypertension. Catheter Cardiovasc Interv. 2006;68(4):642–647. PMID: 16969857.
   PubMed Web of Science ®Google Scholar
• Girona J, Gran F, García B, et al. Percutaneus double stent atrial septostomy. Catheter Cardiovasc Interv. 2007;69(2):227–230. PMID: 17253606.
   PubMed Web of Science ®Google Scholar
• Troost E, Delcroix M, Gewillig M, et al. A modified technique of stent fenestration of the interatrial septum improves patients with pulmonary hypertension. Catheter Cardiovasc Interv. 2009;73(2):173–179. PMID: 19085938.
   PubMed Web of Science ®Google Scholar
• Yadlapati A, Wax D, Rich S, et al. Novel shunt modification with an adjustable stent-embedded “fenestrated” septal occluder in a patient with pulmonary hypertension. Catheter Cardiovasc Interv. 2019;93(7):1382–1384. PMID: 30838741.
   PubMed Web of Science ®Google Scholar
• Kaye DM, Petrie MC, McKenzie S, et al. REDUCE LAP-HF study investigators. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction. ESC Heart Fail. 2019;6(1):62–69. PMID: 30311437.
   PubMed Web of Science ®Google Scholar
• Shah SJ, Feldman T, Ricciardi MJ, et al. One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure (Reduce Lap-HFI) trial: a randomized clinical trial. JAMA Cardiol. 2018;3(10):968–977. PMID: 30167646.
   PubMed Web of Science ®Google Scholar
• Amat-Santos IJ, Del Trigo M, Bergeron S, et al. Left atrial decompression using unidirectional left-to-right interatrial shunt: initial experience in treating symptomatic heart failure with preserved ejection fraction with the W-wave device. JACC Cardiovasc Interv. 2015;8(6):870–872. PMID: 25999114.
   PubMed Web of Science ®Google Scholar
• Rodés-Cabau J, Bernier M, Amat-Santos IJ, et al. Interatrial shunting for heart failure: early and late results from the first-in-human experience with the V-wave system. JACC Cardiovasc Interv. 2018;11(22):2300–2310. PMID: 30391390.
   PubMed Web of Science ®Google Scholar
• Patel MB, Samuel BP, Girgis RE, et al. Implantable atrial flow regulator for severe, irreversible pulmonary arterial hypertension. EuroIntervention. 2015;11(6):706–709. PMID: 26477643.
   PubMed Web of Science ®Google Scholar
• Guimarães L, Del Val D, Rodés-Cabau J. The atrial flow regulator device: expanding the field of interatrial shunting for treating heart failure patients. EuroIntervention. 2019;15(5):398–400. PMID: 31456571.
   PubMed Web of Science ®Google Scholar
• Bakhshaliyev N, Çelikkale İ, Enhoş A, et al. Impact of atrial flow regulator (AFR) implantation on 12-month mortality in heart failure: insights from a single site in the PRELIEVE study. Herz. 2022;47(4):366–373. PMID: 34459929.
   PubMed Web of Science ®Google Scholar
• Shang X, Liu M, Zhong Y, et al. Clinical study on the treatment of chronic heart failure with a novel D-shant atrium shunt device. ESC Heart Fail. 2022;9(3):1713–1720. PMID: 35179320.
   PubMed Web of Science ®Google Scholar
• Kaye D, Shah SJ, Borlaug BA, et al. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure. J Card Fail. 2014;20(3):212–221. PMID: 24487087.
   PubMed Web of Science ®Google Scholar
• Nies RJ, Guthoff H, Mader N, et al. Clinical deterioration after implantation of an interatrial shunt device: case report of an unexpected aetiology. Eur Heart J Case Rep. 2021;5(2):ytab009. PMID: 34268470.
   PubMedGoogle Scholar
• Wakamatsu Y, Nakahara S, Nagashima K, et al. Hot balloon versus cryoballoon ablation for persistent atrial fibrillation: lesion area, efficacy, and safety. J Cardiovasc Electrophysiol. 2020;31(9):2310–2318. PMID: 32613693
   PubMed Web of Science ®Google Scholar